145 related articles for article (PubMed ID: 35018534)
1. Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel Syndrome.
Shah ED
Dig Dis Sci; 2022 Aug; 67(8):3477-3478. PubMed ID: 35018534
[No Abstract] [Full Text] [Related]
2. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
Kane JS; Ford AC
Expert Rev Gastroenterol Hepatol; 2016; 10(4):431-42. PubMed ID: 26753693
[TBL] [Abstract][Full Text] [Related]
3. Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome.
Sayuk GS
Gastroenterol Clin North Am; 2021 Sep; 50(3):611-637. PubMed ID: 34304791
[TBL] [Abstract][Full Text] [Related]
4. Bile Acid Diarrhea Is Associated With Increased Intestinal Permeability Compared With Irritable Bowel Syndrome-Diarrhea.
Magnus Y; BouSaba J; Sannaa W; McKinzie S; Busciglio I; Camilleri M
Gastroenterology; 2022 Apr; 162(4):1343-1345.e1. PubMed ID: 34922946
[No Abstract] [Full Text] [Related]
5. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Carrasco-Labra A; Lytvyn L; Falck-Ytter Y; Surawicz CM; Chey WD
Gastroenterology; 2019 Sep; 157(3):859-880. PubMed ID: 31351880
[TBL] [Abstract][Full Text] [Related]
6. Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes.
Bleser S
Curr Med Res Opin; 2011 Mar; 27(3):503-12. PubMed ID: 21208139
[TBL] [Abstract][Full Text] [Related]
7. [Irritable bowel treatment].
Fassov J; Fynne L; Krarup AL
Ugeskr Laeger; 2016 Aug; 178(35):. PubMed ID: 27592867
[TBL] [Abstract][Full Text] [Related]
8. Irritable Bowel Syndrome with predominant diarrhea and giardiasis: is it one or the other?
Sebastián Domingo JJ
Gastroenterol Hepatol; 2018 Dec; 41(10):647-648. PubMed ID: 29500067
[No Abstract] [Full Text] [Related]
9. Evidence that amitriptyline may be effective in treating diarrhea-predominant irritable bowel syndrome.
Lundberg GD
Medscape J Med; 2008 Jun; 10(6):132. PubMed ID: 18679541
[No Abstract] [Full Text] [Related]
10. A patient with familial Mediterranean fever mimicking diarrhea-dominant irritable bowel syndrome who successfully responded to treatment with colchicine: a case report.
Kumei S; Ishioh M; Murakami Y; Ando K; Nozu T; Okumura T
J Med Case Rep; 2022 Jun; 16(1):247. PubMed ID: 35739566
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Ondansetron for Irritable Bowel Syndrome With Diarrhea.
Black CJ; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):428-429. PubMed ID: 33177346
[No Abstract] [Full Text] [Related]
12. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
[TBL] [Abstract][Full Text] [Related]
13. Is diarrhea-predominant irritable bowel syndrome a low-grade gut inflammatory disorder?
Ghoshal UC
Trop Gastroenterol; 2012; 33(4):239-41. PubMed ID: 23923348
[No Abstract] [Full Text] [Related]
14. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
[TBL] [Abstract][Full Text] [Related]
15. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome.
Camilleri M
Expert Opin Pharmacother; 2013 Jun; 14(9):1151-60. PubMed ID: 23621801
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.
Matsueda K; Harasawa S; Hongo M; Hiwatashi N; Sasaki D
Scand J Gastroenterol; 2008; 43(10):1202-11. PubMed ID: 18618371
[TBL] [Abstract][Full Text] [Related]
17. Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea.
Brenner DM; Sayuk GS
Adv Ther; 2020 Jan; 37(1):83-96. PubMed ID: 31707713
[TBL] [Abstract][Full Text] [Related]
18. Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):858. PubMed ID: 31377275
[No Abstract] [Full Text] [Related]
19. Persistent diarrhoea in a young woman.
Ramnarace R; Ricketts J; Dalton H
BMJ; 2009 Sep; 339():b3369. PubMed ID: 19759088
[No Abstract] [Full Text] [Related]
20. Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.
Lan L; Chen YL; Zhang H; Jia BL; Chu YJ; Wang J; Tang SX; Xia GD
World J Gastroenterol; 2014 Aug; 20(32):11422-8. PubMed ID: 25170231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
